KK
Kunal Kumar Singh
About Kunal Kumar Singh
Data last updated:
Kunal Kumar Singh is a Director at Eltern Segen Pharmaceutical Private Limited (since 2017) and Director at Narina Pharma Private Limited (since 2024). The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Eltern Segen Pharmaceutical Private Limited at ₹6.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Apr 2017 | 2017 | ₹6.3 Lakh (FY 2024) | Active | |
| Director | 15 Feb 2024 | 2022 | Active |
Board colleagues of Kunal Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rahul Kumar Singh | 07740467 | Eltern Segen Pharmaceutical Private Limited | Director |
| Mithlesh Sharma | 09814118 | Narina Pharma Private Limited | Director |
| Sonam Singh | 09814117 | Narina Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kunal Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kunal Kumar Singh
Kunal Kumar Singh currently holds 2 directorships: Eltern Segen Pharmaceutical Private Limited (Director, since 11 Apr 2017, revenue ₹6.3 Lakh (FY 2024)); Narina Pharma Private Limited (Director, since 15 Feb 2024).
Kunal Kumar Singh was first appointed on 11 Apr 2017 as Director at Eltern Segen Pharmaceutical Private Limited. The most recent appointment on record is 15 Feb 2024 at Narina Pharma Private Limited.
The current boards of Kunal Kumar Singh's companies include Rahul Kumar Singh (Eltern Segen Pharmaceutical Private Limited), Mithlesh Sharma (Narina Pharma Private Limited), Sonam Singh (Narina Pharma Private Limited).